These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7598241)

  • 21. Microbial growth and endotoxin production in the intravenous anesthetic propofol.
    Arduino MJ; Bland LA; McAllister SK; Aguero SM; Villarino ME; McNeil MM; Jarvis WR; Favero MS
    Infect Control Hosp Epidemiol; 1991 Sep; 12(9):535-9. PubMed ID: 1940276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth of micro-organisms in solutions of intravenous anaesthetic agents.
    Berry CB; Gillespie T; Hood J; Scott NB
    Anaesthesia; 1993 Jan; 48(1):30-2. PubMed ID: 8434744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of triclosan on the cytotoxicity and fungal growth on a soft denture liner.
    Lefebvre CA; Wataha JC; Cibirka RM; Schuster GS; Parr GR
    J Prosthet Dent; 2001 Apr; 85(4):352-6. PubMed ID: 11319532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.
    Khan ZU; Ahmad S; Mokaddas E; Chandy R
    J Clin Microbiol; 2004 Oct; 42(10):4796-8. PubMed ID: 15472343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of microwave irradiation on the disinfection of complete dentures.
    Silva MM; Vergani CE; Giampaolo ET; Neppelenbroek KH; Spolidorio DM; Machado AL
    Int J Prosthodont; 2006; 19(3):288-93. PubMed ID: 16752628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New method for isolating antibiotic-producing fungi.
    Kawaguchi M; Nonaka K; Masuma R; Tomoda H
    J Antibiot (Tokyo); 2013 Jan; 66(1):17-21. PubMed ID: 23149518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The improved recovery of Candida albicans from fluid culture media.
    Reeder JC; Ganguli LA; Drucker DB; Keaney MG; Gibbs AC
    Microbios; 1989; 60(243):71-7. PubMed ID: 2691863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar.
    Al Mosaid A; Sullivan D; Salkin IF; Shanley D; Coleman DC
    J Clin Microbiol; 2001 Jan; 39(1):323-7. PubMed ID: 11136791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propofol and thiopental in a 1:1 volume mixture is chemically stable.
    Lazar ER; Jolly DT; Tam YK; Hrazdil J; Tawfik SR; Clanachan AS
    Anesth Analg; 1998 Feb; 86(2):422-6. PubMed ID: 9459260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial growth patterns in intravenous fat emulsions.
    Keammerer D; Mayhall CG; Hall GO; Pesko LJ; Thomas RB
    Am J Hosp Pharm; 1983 Oct; 40(10):1650-3. PubMed ID: 6416063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple xylose-based agar medium for the differentiation of Candida dubliniensis and Candida albicans.
    Khan Z; Ahmad S; Chandy R; Joseph L
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):285-7. PubMed ID: 22209683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing Candida albicans growth in parenteral nutrition with and without lipid emulsion: using an established framework to inform maximum duration of infusion policy decisions.
    Austin PD; Hand KS; Elia M
    Clin Nutr; 2014 Jun; 33(3):489-94. PubMed ID: 23891160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of bacterial growth by lignocaine in propofol emulsion.
    Ozer Z; Ozturk C; Altunkan AA; Cinel I; Oral U
    Anaesth Intensive Care; 2002 Apr; 30(2):179-82. PubMed ID: 12002925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4 degrees C.
    Chernin EL; Stewart JT; Smiler B
    Am J Health Syst Pharm; 1996 Jul; 53(13):1576-9. PubMed ID: 8809279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth of nosocomial pathogens in multiple-dose parenteral medication vials.
    Highsmith AK; Greenhood GP; Allen JR
    J Clin Microbiol; 1982 Jun; 15(6):1024-8. PubMed ID: 7050144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth of common bacteria and Candida albicans in 10% soybean oil emulsion.
    Deitel M; Kaminsky VM; Fuksa M
    Can J Surg; 1975 Nov; 18(6):531-5. PubMed ID: 830063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.
    Dumitru R; Hornby JM; Nickerson KW
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2350-4. PubMed ID: 15215080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between Candida albicans and Candida glabrata in biofilms: Influence of the strain type, culture medium and glucose supplementation.
    Hosida TY; Cavazana TP; Henriques M; Pessan JP; Delbem ACB; Monteiro DR
    Mycoses; 2018 Apr; 61(4):270-278. PubMed ID: 29274093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits.
    Fredriksson A; Pontén E; Gordh T; Eriksson P
    Anesthesiology; 2007 Sep; 107(3):427-36. PubMed ID: 17721245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.